Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Bacteremia"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Bacteremia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Condition: Bacteremia
Interventions: Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: Cefazolin
2 Recruiting Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment durations;   Other: 14 days of adequate antibiotic treatment durations
3 Recruiting Duration of Antibiotics for the Treatment of Gram-negative Bacilli Bacteremia
Condition: Gram Negative Bacteremia
Interventions: Drug: short-course antibiotic treatment;   Drug: accepted prolonged antibiotic treatment
4 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin 10mg/kg/24h iv
5 Recruiting The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia
Condition: Staphylococcus Aureus Bacteremia
Intervention: Procedure: FDG PET CT
6 Recruiting A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus
Condition: Staphylococcus Aureus Bacteremia
Interventions: Biological: 514G3;   Drug: Placebo;   Drug: Standard IV antibiotic therapy
7 Not yet recruiting BALANCE on the Wards: A Pilot RCT
Condition: Bacteremia
Interventions: Other: 7 days of adequate antibiotic treatment;   Other: 14 days of adequate antibiotic treatment
8 Recruiting Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Conditions: Methicillin Susceptible Staphylococcus Aureus Septicemia;   Bacteremia
Interventions: Drug: Daptomycin;   Other: Placebo
9 Not yet recruiting An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures
Conditions: Bacteraemia;   Endocarditis
Interventions: Drug: Amoxicillin;   Drug: Amoxicillin-Potassium Clavulanate
10 Recruiting IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Condition: Bacteremia
Interventions: Drug: Daptomycin;   Drug: Vancomycin;   Drug: Ceftaroline
11 Recruiting Procalcitonin Levels as a Predictor of Bacteremia in Febrile Pediatric Oncology Patients-Pilot Study
Conditions: Cancer;   Bacteremia
Intervention:
12 Recruiting Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Conditions: Cholangitis;   Bacteremia
Intervention: Procedure: Cholangioscopy
13 Recruiting Safety Evaluation of Seraph® to Reduce Bacteremia in Patients on Hemodialysis
Conditions: Bacteremia;   Bacterial Infection
Intervention: Device: Seraph Microbind Affinity Blood Filter
14 Recruiting Preventing Catheter-related Bacteremia When Administering Injectable Medications in Premature Infants.
Conditions: Bacteremia;   Infant, Very Low Birth Weight
Interventions: Device: Edelvaiss Multiline NEO;   Device: Standard Infusion Set
15 Recruiting T2Bacteria Panel Pivotal Study
Condition: Bacteremia
Intervention:
16 Recruiting Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
Condition: Bacteremia
Intervention: Drug: Vancomycin
17 Recruiting Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Condition: Gram-Negative Bacterial Infections
Intervention:
18 Recruiting Safety and Bacteraemia Between Peripherally Inserted and Central Inserted Catheters.
Condition: Catheter Related Infections
Interventions: Device: CVC;   Device: PICC
19 Recruiting Prevention of Nosocomial Bacteremia Among Zambian Neonates
Conditions: Neonatal Sepsis;   Neonatal Mortality
Interventions: Drug: Chlorhexidine gluconate (CHG);   Behavioral: Hand hygiene (HH);   Behavioral: Infection control training;   Other: Infection control reminders via SMS text
20 Recruiting The Association Between Advancing Age and Mortality at 30 Days in Patients With Bacteremia E. Coli Beta-lactamase Phenotype Extended Spectrum RC15_0421
Condition: Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.